Anal Cancer
161
31
47
70
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
29 trials with published results (18%)
Research Maturity
70 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
10.6%
17 terminated out of 161 trials
80.5%
-6.1% vs benchmark
7%
12 trials in Phase 3/4
41%
29 of 70 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 70 completed trials
Clinical Trials (161)
Distance-Based Exercise to Preserve Function and Prevent Disability
Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
DESTINY-PANTUMOUR04
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
Integrated Cancer Repository for Cancer Research
ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer
COQ10 and Vitamin E for Off-Target Radiation Toxicity
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
Individual Following in Anal Cancer With PET/CT
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Blood Biomarkers Based Screening for HPV-driven OPC
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
Self-sampling to Optimize Anal Lesion Outcomes
Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis